The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Original Article

Filter Newest Oldest Showing 61-80 of 100 results
Original Article / VOLUME 3, ISSUE 3, DECEMBER 2021

Evaluation of Regulatory T Cells in Chronic Hepatitis C Patients

Yeşim Tuyji-Tok and others

Hepatitis C virus (HCV), defined as a non-A non-B hepatitis agent in 1989, is a hepatotropic, noncytopathic, positive-stranded ribonucleic acid (RNA) virus from the family Flaviviridae. HCV infection is an acute or chronic necroinflammatory (...) Read More

Original Article / VOLUME 3, ISSUE 3, DECEMBER 2021

Do the Most Cited Web Sources Provide Proper Information on Influenza Vaccination?

Elif Mukime Sarıcaoğlu and others

Influenza constitutes one of the major threats to the health system, affecting up to 10% of the world’s population every year. According to the Centers for Disease Control and Prevention (CDC) database, between 1999-2015, 291,000-646,000 deaths caused by influenza-associated respiratory disease(...) Read More

Original Article / VOLUME 3, ISSUE 2, AUGUST 2021

Diabetic Foot Infections and Outcomes: A Single Center Study

Derya Yapar and others

Diabetes is a widespread metabolic disease in the world. Diabetic foot, which develops in cases where diabetes control is not provided, is a clinical picture that impairs the quality of life of cases and sometimes leads to undesirable consequences including limb amputation. The global prevalence (...) Read More

Original Article / VOLUME 3, ISSUE 2, AUGUST 2021

The Effects of Polypharmacy, Nutritional and Functional Status on the Progression of COVID-19 in Older Adults

Asiye Bahar Kaçmaz and others

The SARS-CoV-2 infection has influenced the whole world and every day, both the number of cases and deaths related to the COVID-19 pandemic continue to rise. Eighty-one percent of COVID-19 cases are mild, 14% are serious and 5% are critical. Although the overall mortality rate was 2.3%, mortality (...) Read More

Original Article / VOLUME 3, ISSUE 2, AUGUST 2021

Infectivity of Adult and Pediatric COVID-19 Patients

Mahir Kapmaz and others

The clinical findings of SARS-CoV-2 infection are heterogeneous, and the duration of viral RNA shedding varies on the age of the patient, severity of the disease, and type of the sample. For that reason, a comprehensive analysis of the dynamics of viral shedding is critical for (...) Read More

Original Article / VOLUME 3, ISSUE 2, AUGUST 2021

Predictors of COVID-19 among Healthcare Workers who were Exposed to COVID-19

Çiğdem Erol and others

SARS-CoV-2 is transmitted via the inhalation of infected droplets or through direct contact with contaminated surfaces. Aerosol-generating procedures can also lead to airborne transmission. Healthcare workers (HCWs) are at higher risks for infections than the general (...) Read More

Original Article / VOLUME 3, ISSUE 1, APRIL 2021

The Impact of C Reactive Protein in Prediction of the Outcome in Infective Endocarditis

Serap Şimşek-Yavuz and others

Infective endocarditis (IE), among the most common life-threatening infection, is a serious disease causing substantial morbidity and mortality. Determining at-risk patients and following them up closely with appropriate interventions are necessary to decrease complications and mortality. Treatment response to infective endocarditis is followed up with the combination of relief of symptoms, blood cultures, echocardiographic investigations and laboratory tests. A simple and widely available test Read More

Original Article / VOLUME 3, ISSUE 1, APRIL 2021

The role of Isolation of the Patients on Hospital Admission for Prevention of Nosocomial Infections

Şiran Keske and others

Healthcare-associated infections (HAI) is an increasing global problem all over the world. Multidrug-resistant (MDR) pathogens, including carbapenem-resistant Gram-negative Enterobacterales, Pseudomonas spp. and Acinetobacter spp. have become common causes of HAI, such as central line-associated bloodstream infections (BSIs), catheter-associated urinary tract infections (UTIs), surgical site infections (SSIs) and ventilatory associated pneumonia (VAPs). These infections increase not only mortality but also healthcare Read More

Original Article / VOLUME 3, ISSUE 1, APRIL 2021

Persistent Symptoms After Discharge of COVID-19 Patients

Oğuz Evlice and others

Introduction More than a year has passed since the beginning of the COVID-19 pandemic, and we are learning more about the long-term effects of the disease. While many patients recover completely, some continue to experience fatigue, dyspnea, cough, joint pain, and chest pain for weeks or even months (1).The UK National Institute for Health and […] Read More

Original Article / VOLUME 2, ISSUE 3, DECEMBER 2020

Effectiveness of Surgical Prophylaxis Where the Antibiotic Resistance is High

Mehtap Aydın and others

Surgical site infections (SSI) are defined as infections that occur up to 30 days or one year after surgery in patients with implants, affecting the incision or deep tissue at the surgery site. They account for 20% of all healthcare-associated infections (HAI) in hospitalized patients. Patients with SSI are hospitalised additionally 7-11 days postoperatively. Read More